About Dedeepya Pharma
Dedeepya Pharma is a company based in India. Dedeepya Pharma offers products and services including Ceftriaxone and Meropenem.
- Headquarter India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Dedeepya Pharma Pvt. Ltd
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$10.79 M (USD)353.14as on Mar 31, 2023
-
Net Profit
$305.48 K (USD)860.06as on Mar 31, 2023
-
EBITDA
$469.03 K (USD)276.77as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dedeepya Pharma
Dedeepya Pharma offers a comprehensive portfolio of products and services, including Ceftriaxone and Meropenem.
This product is manufactured as an injectable for treating bacterial infections and is supplied for use in critically ill patients.
This medication is provided in injection form for addressing severe infections and is included in the portfolio of supportive treatments.
Funding Insights of Dedeepya Pharma
Detailed funding history for Dedeepya Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dedeepya Pharma
Investment portfolio details for Dedeepya Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dedeepya Pharma
Detailed financials for Dedeepya Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dedeepya Pharma Comparisons
Peer comparison for Dedeepya Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dedeepya Pharma
Detailed competitors of Dedeepya Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dedeepya Pharma
Complete news archive for Dedeepya Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dedeepya Pharma
Dedeepya Pharma is headquartered in India.
Annual revenue of Dedeepya Pharma is $10.79M as on Mar 31, 2023.
Dedeepya Pharma is recognized as an emerging Indian pharmaceutical company that focuses on sustaining life and promoting healthcare through the provision of high-quality, effective, and affordable medicines for a broad spectrum of conditions. Products are thoroughly assessed for safety, quality, and efficacy to ensure they can be utilized with confidence across all stages of life. The company strives towards innovation in medicine to meet unmet needs in therapy areas while upholding values like commitment, passion, teamwork, and quality. Accessibility to these formulations is emphasized to contribute to better health outcomes in India.
Dedeepya Pharma offers Ceftriaxone and Meropenem.